Latest Insider Transactions at Prestige Consumer Healthcare Inc. (PBH)
This section provides a real-time view of insider transactions for Prestige Consumer Healthcare Inc. (PBH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Prestige Consumer Healthcare Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Prestige Consumer Healthcare Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 02
2024
|
Adel Mekhail EVP, Marketing & Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
1,288
-3.51%
|
$91,448
$71.26 P/Share
|
|
Mar 01
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
172
-0.54%
|
$12,040
$70.42 P/Share
|
|
Mar 01
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
172
+0.53%
|
$7,396
$43.87 P/Share
|
|
Feb 28
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
662
-2.03%
|
$46,340
$70.28 P/Share
|
|
Feb 28
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
662
+1.99%
|
$28,466
$43.87 P/Share
|
|
Feb 27
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
1
-0.01%
|
$70
$70.0 P/Share
|
|
Feb 27
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
1
+0.01%
|
$57
$57.18 P/Share
|
|
Feb 26
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
9,677
-23.28%
|
$677,390
$70.44 P/Share
|
|
Feb 26
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
9,677
+18.9%
|
$416,111
$43.87 P/Share
|
|
Feb 23
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
23
-0.07%
|
$1,610
$70.0 P/Share
|
|
Feb 23
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
23
+0.07%
|
$989
$43.87 P/Share
|
|
Feb 15
2024
|
Adel Mekhail EVP, Marketing & Sales |
SELL
Open market or private sale
|
Direct |
15,549
-27.92%
|
$1,072,881
$69.15 P/Share
|
|
Feb 15
2024
|
Adel Mekhail EVP, Marketing & Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
15,549
+21.32%
|
$544,215
$35.09 P/Share
|
|
Feb 14
2024
|
William P'Pool Officer |
SELL
Open market or private sale
|
Direct |
26,019
-34.28%
|
$1,743,273
$67.9 P/Share
|
|
Feb 14
2024
|
William P'Pool Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,019
+25.52%
|
$1,170,855
$45.02 P/Share
|
|
Feb 14
2024
|
Christine Sacco CFO & COO |
SELL
Open market or private sale
|
Direct |
30,019
-35.37%
|
$2,041,292
$68.25 P/Share
|
|
Feb 14
2024
|
Christine Sacco CFO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,788
+34.76%
|
$718,852
$29.46 P/Share
|
|
Feb 08
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
5,336
-25.09%
|
$368,184
$69.0 P/Share
|
|
Feb 08
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
5,336
+20.06%
|
$298,816
$56.11 P/Share
|
|
Sep 14
2023
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
2,540
-13.75%
|
$147,320
$58.92 P/Share
|
|
Sep 14
2023
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
2,540
+12.09%
|
$76,200
$30.56 P/Share
|
|
Aug 08
2023
|
Ronald M. Lombardi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
32,800
-2.78%
|
$2,164,800
$66.47 P/Share
|
|
Aug 08
2023
|
Ronald M. Lombardi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,800
+9.76%
|
$1,082,400
$33.5 P/Share
|
|
Aug 01
2023
|
John E Byom Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+4.36%
|
-
|
|
Aug 01
2023
|
Celeste A. Clark Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+19.91%
|
-
|
|
Aug 01
2023
|
James D Arecca Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+50.0%
|
-
|
|
Aug 01
2023
|
Sheila Hopkins Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+8.16%
|
-
|
|
Aug 01
2023
|
Natale S Ricciardi Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+7.81%
|
-
|
|
Aug 01
2023
|
Dawn M. Zier Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+15.79%
|
-
|
|
May 24
2023
|
Christine Sacco CFO & COO |
SELL
Open market or private sale
|
Direct |
55,294
-32.21%
|
$3,317,640
$60.07 P/Share
|
|
May 24
2023
|
Christine Sacco CFO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
37,029
+21.63%
|
$1,888,479
$51.75 P/Share
|
|
May 19
2023
|
Adel Mekhail EVP, Marketing & Sales |
SELL
Open market or private sale
|
Direct |
17,194
-31.33%
|
$1,066,028
$62.83 P/Share
|
|
May 19
2023
|
Adel Mekhail EVP, Marketing & Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
17,194
+23.8%
|
$515,820
$30.19 P/Share
|
|
May 15
2023
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
8,154
-33.85%
|
$472,932
$58.8 P/Share
|
|
May 15
2023
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
8,154
+25.29%
|
$236,466
$29.46 P/Share
|
|
May 04
2023
|
Jeffrey Zerillo Senior VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,482
-3.04%
|
$153,884
$62.02 P/Share
|
|
May 04
2023
|
Jeffrey Zerillo Senior VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,063
+8.99%
|
-
|
|
May 04
2023
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
2,056
-5.82%
|
$127,472
$62.02 P/Share
|
|
May 04
2023
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
3,364
+15.75%
|
-
|
|
May 04
2023
|
Ronald M. Lombardi Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
48,123
-7.63%
|
$2,983,626
$62.02 P/Share
|
|
May 04
2023
|
Ronald M. Lombardi Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
87,854
+21.61%
|
-
|
|
May 04
2023
|
Adel Mekhail EVP, Marketing & Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
2,681
-6.4%
|
$166,222
$62.02 P/Share
|
|
May 04
2023
|
Adel Mekhail EVP, Marketing & Sales |
BUY
Grant, award, or other acquisition
|
Direct |
5,587
+20.73%
|
-
|
|
May 04
2023
|
William P'Pool Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,860
-6.86%
|
$239,320
$62.02 P/Share
|
|
May 04
2023
|
William P'Pool Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+17.17%
|
-
|
|
May 04
2023
|
Christine Sacco CFO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,203
-6.15%
|
$384,586
$62.02 P/Share
|
|
May 04
2023
|
Christine Sacco CFO & COO |
BUY
Grant, award, or other acquisition
|
Direct |
9,968
+16.23%
|
-
|
|
May 03
2023
|
Ronald M. Lombardi Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,167
-1.35%
|
$193,187
$61.25 P/Share
|
|
May 03
2023
|
Adel Mekhail EVP, Marketing & Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
469
-2.89%
|
$28,609
$61.25 P/Share
|
|
May 03
2023
|
Christine Sacco CFO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,216
-2.85%
|
$74,176
$61.25 P/Share
|